important because it is potentially reversible and correction may improve outcome. 6, 7 Various methods are used to determine plasma fibrinogen concentration, such as the Clauss method, antigen determination, and viscoelastic measurements by means of thromboelastometry. 8, 9 Currently, the most commonly used assay is the fibrinogen Clauss assay (Fc), where a high concentration of thrombin is added to diluted citrated plasma followed by measurement of the clotting time (CT). [9] [10] [11] [12] The CT of fibrinogen is measured by mechanical or photo-optical principles. The mechanical method identifies dissociation of a metal ball from a magnetic field upon clot formation, whereas the photo-optical method records alteration in turbidity. 12 In the mechanical method, time measurement is started after the addition of thrombin reagent to the plasma sample and is stopped when the contact of a steel ball and a magnetic sensor is broken because of its incorporation into the fibrin network. 13 A predetermined standard curve of CT against fibrinogen concentration is used to read Fc, which is inversely correlated with CT. 12, 14 Several studies have documented that standard coagulation tests are time-consuming and not effective to identify patients with increased risk of bleeding. 7, [15] [16] [17] Rotational thromboelastometry (ROTEM) allows a preliminary evaluation of coagulation within 10 minutes, compared to the 45-60 minutes for plasma coagulation assays, enabling effective implementation of therapeutic interventions. 10, 18, 19 The extrinsic-
activated ROTEM (EXTEM) assay is activated by proprietary tissue factor, whereas the intrinsic-activated ROTEM (INTEM) assay is activated by ellagic acid and phospholipid. The fibrin polymerization test (FIBTEM)
is an EXTEM-based assay with the addition of cytochalasin D to inactivate the platelets. 20 The FIBTEM assay indicates the formation and stability of the fibrin clot. 21 In people, FIBTEM maximum clot firmness (MCF FIBTEM ) is used as a parameter representing the functional wholeblood fibrinogen concentration. 3, 11, 18 Correlation of Fc and MCF FIBTEM has been investigated in people and cats but not in dogs. 3, 7, 10, 19, [22] [23] [24] The correlation of other thromboelastometry parameters and plasma coagulation tests has been investigated in clinically healthy dogs, showing only moderate correlation. 25 The purpose of our study was to determine correlations between Fc and MCF FIBTEM and between the plasmatic coagulation tests prothrombin time (PT) and activated partial thromboplastin time (aPTT) with ROTEM parameters in a population of healthy and sick dogs and to identify factors that influence this correlation. Our hypothesis was that a correlation exists between Fc and plasma coagulation times and ROTEM parameters. Furthermore, the ability of plasma coagulation tests and ROTEM parameters to predict bleeding in dogs was evaluated. [26] [27] [28] [29] Briefly, 300 μL citrated blood was allowed to stand for approximately 10 minutes in the 37 C warming chamber of the device followed by analysis using an automated pipette and single portion reagents. 
| MATERIALS AND METHODS

| Data collection and classification
| Data analyses and statistics
Data were manually entered or copied (ROTEM parameters) into a spreadsheet. Statistical analyses were performed using the statistical software package SPSS (IBM SPSS statistics 25.0, Armonk, NY, USA).
Continuous data were tested for normality using the Shapiro-Wilk test. Depending on the underlying distribution, data were expressed as mean and SD or median and range. Nonparametrically distributed continuous variables were compared using the Mann-Whitney U test.
A Student's t test was performed to detect differences between patient groups with parametrically distributed continuous variables.
The chi-square test was used to evaluate the associations between categorical variables. Correlation of parametric data was assessed using the Pearson method. For nonparametrically distributed data, Spearman's correlation was used for analysis. The accuracy of standard coagulation tests and ROTEM to determine dogs with clinical sings of bleeding was evaluated using receiver operating characteristics (ROC) and the area under the ROC curve (AUC). You den's J statistic was used to select the optimum cutoff point of the ROC curves.
A P-value <.05 was considered statistically significant.
| RESULTS
The database search identified 108 dogs with concurrent ROTEM and Correlations among ROTEM parameters, Fc, and plasma coagulation times including subgroup analysis are summarized in Table 1 .
Fibrinogen Clauss was strongly correlated with MCF FIBTEM (r = 0.860, P < .001; Figure 1 ). PT was strongly correlated with CT EXTEM (r = 0.839, P < .001) and strongly correlated with CFT EXTEM (r = 0.695, P < .001; Table 1 and Figure 2 ). For aPTT, the best correlation was found between CT INTEM and aPTT (r = 0.664, P < .001; Table 1 and Figure 3 ).
Mean or median ROTEM parameters generated with EXTEM-S, INTEM-S, and FIBTEM-S analysis, and available hematology and coagulation parameters are presented in Table 2 ).
The specific parameters and their cutoff values for detecting dogs with clinical signs of bleeding analyzed with ROC are shown in Table 3 . The definition of hypocoagulability used showed a sensitivity of 60% and a specificity of 65% to detect bleeding (P = .04). visualizes the clot that forms from cross-linked fibrin strands, erythrocytes, and factor XIII. 36 In contrast to fibrinogen determined by the Clauss method, MCF FIBTEM represents a stable clot and requires functional fibrinogen that is not only cleaved to fibrin polymers but also cross-linked. 11 The FIBTEM-S assay further provides additional information regarding the clot strength and clot lysis. 33 The MCF FIBTEM therefore is believed to predict the function of fibrinogen better rather than Fc and is increasingly used for guidance of fibrinogen treatment in people. An additional explanation for decreased correlation may be a residual platelet effect on MCF FIBTEM that becomes more important the more hypofibrinogenemic a patient becomes. 21 In addition, anemia may lead to a hypercoagulable FIBTEM tracing because of higher concentrations of coagulation factors in a whole-blood sample with a decreased hematocrit, whereas Fc is not affected by hematocrit. 25, 41 In our study, correlation of Fc with MCF FIBTEM was higher in blood samples with a hematocrit below the reference interval. In contrast to
| DISCUSSION
Fc, MCF FIBTEM depends on hematocrit 42 and an effect on correlation with changes in hematocrit is expected. Both correlations were assessed as strong to very strong; therefore, the clinical importance of hematocrit changes remains to be determined.
Of note, some dogs with Fc within the reference interval did not show clotting in the FIBTEM-S analysis (green line). Again, this observation can be explained by the different measurement end points and implies that fibrinogen is present and to some degree functional, but a stable clot cannot be formed. The addition of thrombin in excess (as used in the Clauss method) to some extent overcomes inhibiting factors of clot generation that may lead to a decrease in MCF FIBTEM . 11, 43 In these cases, the fibrinogen concentration is overestimated by the Clauss method in relation to MCF FIBTEM .
11,43
Other reasons for a lack of correlation are test interference by dysfunctional fibrinogen protein in the blood sample, hyperfibrinolysis of circulating fibrin, or a deficiency of factor XIII. 10, [44] [45] [46] During fibrinolytic treatment or in hyperfibrinolytic conditions, fibrin or fibrinogen degradation products inhibit fibrin polymerization, leading to a relatively low fibrinogen concentration as measured by the Clauss method. [47] [48] [49] However, MCF FIBTEM theoretically also should be blunted by fibrin degradation products, and the correlation in hyperfibrinolytic dogs was better than in the whole population. Fibrinogen degradation products were not measured in our study, and because dogs with hyperfibrinolysis showed an even stronger correlation of Fc with MCF FIBTEM , hyperfibrinolysis as a cause of the low MCF FIBTEM compared to normal Fc concentration seems unlikely. However, because of the low number of dogs experiencing hyperfibrinolysis, we believe that this result should be interpreted with caution. Overall, MCF FIBTEM can be used in dogs to approximate the plasma fibrinogen concentration and function as described in people and in cats.
19,21
We also found a very strong correlation between CT EXTEM and PT and a strong correlation between aPTT and CT INTEM . The identified correlations are stronger than previously described in healthy dogs. The measuring method of aPTT is identical; but instead of thromboplastin, phospholipids are added. 50 At that time, approximately 5% of the total thrombin has been generated. 51 In contrast, CT EXTEM/INTEM represents the time from activation of the extrinsic pathway by tissue factor or ellagic acid to the start of clot building in a whole-blood sample and evaluates the initiation phase of thrombin generation. 52 Notably, CT is measured in whole blood and involves interaction with platelets and red blood cells. Again, the presence of red blood cells is expected to influence viscoelastic coagulation test results 25 and explain some of the discrepancies in correlation.
The comparison of dogs with and without clinical signs of bleeding and possible anticipation of probability to bleed based on coagulation parameters including ROTEM parameters was an additional aim of our study. Hematocrit and platelet count were lower in dogs with bleeding compared to dogs in the non-bleeding group.
The significantly lower hematocrit was attributed to hemorrhage, but we cannot exclude other reasons for anemia. Although the mean platelet count was significantly lower in the bleeding group, both groups had platelet counts within the reference interval, implying that the lower platelet count was not the main reason for bleeding. In contrast, the median standard plasma coagulation tests PT and aPTT were both significantly prolonged in bleeding dogs and above the reference interval in 50% of the bleeding dogs. Prolongations in PT and aPTT can be the cause or result of bleeding, and neither of the parameters showed good sensitivity for the detection of bleeding. However, Because bleeding can be caused by the lack or deficiency of any factor or mechanism of hemostasis, it seems prudent that in a heterogeneous population of dogs with bleeding, a single parameter is not helpful to predict bleeding. Because ROTEM allows examination of many aspects of hemostasis in whole blood, a combination of ROTEM parameters, which evaluate the different steps of hemostasis, is expected to be superior to predict bleeding. However, the definition of hypocoagulability used in our study, as well as in previous studies, 30, 31, 55, 56 did not identify a useful sensitivity to predict bleeding. We suspect that a more complex scoring system is needed to predict bleeding in dogs, similar to that described in people. 57 Being retrospective in nature, our study has several limitations.
Dogs were included if they had concurrent Fc and FIBTEM analysis and standard coagulation tests, and EXTEM and INTEM assays were not additionally available for all dogs. Subgroup analysis and the CT INTEM /aPTT correlation therefore should be interpreted with caution and requires larger studies to identify confounding factors.
Furthermore, because we examined a heterogeneous population of clinically ill dogs, some dogs were pretreated with fluids or other medications, including NSAIDs, which may have had an effect on the test results. Because correlation was improved when pretreated patients were compared to untreated dogs, we believe this effect is negligible and potentially affected both tests. Additional studies are needed to evaluate the impact of confounding factors in more detail.
As a 3rd limitation, our diagnosis of bleeding was based on clinical signs and we therefore cannot make any statement regarding bleeding that was not clinically apparent.
In conclusion, MCF FIBTEM can be used to evaluate the effect of plasma fibrinogen on hemostasis as an alternative to determination of Fc. In addition, CT EXTEM and CT INTEM were strongly correlated with PT and aPTT, respectively, and can be used to assess the extrinsic and intrinsic pathways of clot formation. None of the assessed parameters could predict bleeding with both high sensitivity and high specificity.
However, CT INTEM >149 seconds was 100% sensitive to detect bleeding therefore could be used more frequently for identification of coagulation disorders in the future.
